vaccines like the annual flu vaccines. people saw they took other vaccines that worked and so were ready to put their trust in getting the covid vaccine. what do you think? we want to know what you think about whether you are going to get the covid-19 vaccine this year. let's go to our phone lines. let's go to jerome, calling from detroit, michigan. drum says he does not plan to get it this year. -- jerome says he does not plan to get it this year. good morning. are you there? let's go to jim, calling from new york. he says he plans to get the covid vaccine this year. good morning. caller: good morning. glad to see you doing the show. i have to get the vaccine. i have heart disease. i have a rare autoimmune disease. and i never get more [indiscernible] and i trust the science. my wife is scared to death to bring it home to me. we are still married after 30 years. i have to sleep. we can both ease our minds. tim, callingalk to from alabama. he says no, he will not get the vaccine this year. good morning. caller: i am not ge

and many vaccine platforms and several vaccine. developers to do so and so kindly ab you know at. there are that can be technical glitches promises may not be met and therefore the current biggest hurdle indeed effects in supply and a vaccine delivery shortfalls max the world health organization has criticized the announcement of export controls on covert $1000.00 vaccines produced within the block the w.h.o. says that such measures risk prolonging the pandemic w.h.o. has also warned about the dangers of vaccine nationalism how worrying is all this to you. i think it's deeply deeply worrying because the longer it takes to vaccinate the world the less like a we are to get to herd immunity the more likely that our existing vaccines will become ineffective but i think what we're seeing with the e.u. is they're getting almost a taste of their own merits and we are relying on a few pharmaceutical corporations who are seeking to have exclusive rights and have intellectual property so that means we're saying are to shortages of these vacc

so far you know we are staying growing momentum for a people's vaccine for a vaccine for the vaccine science to be shed openly without intellectual property barriers so that more manufacturers can get on board to produce the vaccine for many many. current leaders formally does the president of south africa leaders in pakistan we're seeing that momentum grow unfortunately we're not yet seeing any big step any big changes on the part of rich countries governments and of course these are critical players because they're the home to the big pharmaceutical corporations that have developed that seems that have been approved we need those governments to call for people's vaccine to call on those pharmaceutical corporations to change tack share their vaccine science and know how so we can ramp up production and ensure that everybody everywhere even in the poorest countries in the most fragile context can access a vaccine hellen south africa is using the vaccine made jointly by researchers at the university of oxford in the biotech firm astra zeneca is this going to be a game changer since it

the vaccines. that skepticism is grounded in abuses bypassed health authorities, sometimes in government names, biased health systems, symptoms of suffering among people of color, and also modern-day public health programming that deals ineffectively with social determinants of health. we need to focus in particular on that second set of hesitancy, the second kind. the second action here is recalibrating our ideas about the tempo of work needed to improve covid-19 vaccine uptake among communities of color. few of us doubt that a real race is on, even though the finish line may have to be redrawn due to bottlenecks and vaccine supply and administration. for communities of color, the campaign has to engage in two very differently paste work streams. the first is the urgent task of reducing disease transmission and burden, but the second work stream is not to be rushed and ongoing job of demonstrating trustworthiness and earning a reputation for reliability and honesty, while trust is an intangible pr

yes. vaccine is precious. yes, absolutely, _ vaccine is precious.utely, very precious. vaccine is precious. yes, - absolutely, very precious. we vaccine is precious. yes, _ absolutely, very precious. we were really happy to be able to clarify that yesterday with some news from nhs england that gps were able to use any sort of leftover vaccines to start vaccinating the next cohort, the third one, those over 75. how eas in the third one, those over 75. how easy in practice — the third one, those over 75. how easy in practice is _ the third one, those over 75. how easy in practice is it _ the third one, those over 75. how easy in practice is it to _ the third one, those over 75. how easy in practice is it to do that because people are not necessarily that fleet of foot and managing to get to where they need to be in time? ~ , ,., , get to where they need to be in time? ~ ,,., , ~ ., get to where they need to be in time? ~ , , ~ ., ., get to where they need to be in time? �* , , 4' ., . , , time? absolutely, we know that gps have been spending _ time? a

time where actually there's more vaccine available and is being requested for vaccination within the 1a group to the ac ipn cdc guidelines that came out on vaccinations to the states were never meant to be some out finish the first phase then you move to the second phase and then he moved to the third. so i'm here as a cdc director to ask our governors to echo what the secretary said and strongly recommend the vaccination now the expand to those individuals 65 or older, and those individuals between 16- 18 depending on the vaccine being used to 64 that have a comorbidity with the medical documentation of such. we clearly have enough vaccine at this point to begin to expand and get more and more of the vulnerable individuals in our country vaccinated. this is particularly important right now as we are seeing the post holiday surge surge. we have many jurisdictions now that are on the verge of going from a linear growth to basically exponential growth, and we believe it's important at this time to get those most vulnerable people as quickly as we can in the vaccination programs as the

the big job here is to develop the vaccination _ vaccination.n to those individuals— develop the vaccination to those individuals festival— develop the vaccination to those individuals festival to _ develop the vaccination to those individuals festival to those - develop the vaccination to those individuals festival to those whoj individuals festival to those who are at _ individuals festival to those who are at high— individuals festival to those who are at high risk— individuals festival to those who are at high risk of— individuals festival to those who are at high risk of death - individuals festival to those who are at high risk of death and - are at high risk of death and hospitalisation _ are at high risk of death and hospitalisation and - are at high risk of death and hospitalisation and then - are at high risk of death and hospitalisation and then to i are at high risk of death and . hospitalisation and then to the are at high risk of death and - hospitalisation and then to the rest of the _ hospitalisation and then to the rest of the p

executivenounced an order on enhanced data reporting of vaccinations and the expansion of vaccinations to seniors over 75 and teachers. this is 50 minutes. minutes. >> good evening, joining me are major general tim gallen of the maryland national guard r chan the department of health. we began 2021 at a critical moment in the war against covid-19 which continues to pose a serious threat to our state and our nation. while the initial launch of the vaccine distribution, this does offer a glimmer of hope, we still have a long way to go in this fight, distributing and administering vaccines throughout 2021 will be without question the greatest peace time undertaking in american history and it will be a massive all hands on deck ongoing operation involving the federal, state and local government and the private sector. over the last nearly three weeks, we have already successfully allocated deployed and distributed 270,000, 150 doses of vaccines directly into the hands of our front-line vaccinate her's at hospitals, nursing homes and local health departments to begin phase one a of vulnerab

not to develop a measles vaccine but to develop a polio vaccine.eason why i point this out is because in fact, there was this back-and-forth going on. in war, we had a different set of priorities. scientific attention was focused on those. after the war, our scientific priorities shifted again. once we came up with a polio vaccine, the technology that was developed to produce that polio vaccine was used as the basis and inspiration for a number of vaccines that followed. we ended up with a bunch of new vaccines and the 1960's. -- vaccines in the 1960's. there was this back-and-forth of scientific attention being focused on different diseases depending on what the national priority was at the time. we already know from the early clip that the polio vaccine that made it across the finish line first was the one developed by jonas salk. he was determined that he had the vision for what was going to be an effective vaccine. with the foundation's help, one of the biggest vaccine trials was conducted with something like 1.2 million american children. i th

vaccines, the covid vaccine? you have written, for example, some of the concerns around the allergic reaction to the vaccines are not necessarily that different from allergic reactions. easy to other very common vaccines, including the flu vaccine. what do you think some of the misinformation is that is going around and how can it be counteracted? >> this is a huge problem because the anti-vaccine groups now, which historically have gone after the hbv vaccine and other cancers come has that a lot of damage in terms of getting parents not to vaccinate their kids or adolescents, are now turning their attention to covid-19 vaccines and prevention measures. so there is quite a laundry list now i things they are alleging. play this game of whack-a-mole. you not going down, another pops up. the first was these high rates of allergic reactions that kill, is not true. the rate of anaphylaxis in the pfizer moderna vaccine has now been looked at around 3 million of 5 million, which is a little high than the anaphylaxis rat

vaccines. we're getting them out the door as soon as we have them and we don't have control over all the ones that come to san francisco, but maybe you can talk about the path that a vaccine follows from when it is assigned to san francisco to when it is administered. and i know that you can probably only mostly speak to what happens with the department of public health, because we only have control over the vaccines that we receive. >> should i start? or would you? >> maybe i'll start with the logistical part and then you can talk about the clinical implications. because these vaccines were processed in a very quick manner, they require a little bit more logistical effort than normal vaccines. so the pfizer vaccine needs ultra-cold freezing which is -60° and that's not normally how we distribute vaccines. so that temperature control is extremely important for the vaccines to remain effective. at every stage from when they are produced at the manufacturing and as well as transport across the co

all this is— vaccine, vaccines and israel.evening. the american pharmaceutical company merck is dissing continuing its vaccines — company merck is dissing continuing its vaccines that were hoping to record — its vaccines that were hoping to record to — its vaccines that were hoping to record to be effective and i'll say they're _ record to be effective and i'll say they're not— record to be effective and i'll say they're not going to continue with those _ they're not going to continue with those experiments. is are huge issues, — those experiments. is are huge issues, and that's becomes political and as— issues, and that's becomes political and as countries fight and compete with each— and as countries fight and compete with each other we are losing the bil with each other we are losing the big picture. which is no matter how you might _ big picture. which is no matter how you might shut borders, it's a global— you might shut borders, it's a global pandemic, and if we don't get it under— global pandemic, and if we don't get it

get vaccinated, to mobilize more medical teams to get shots in people's arms, to increase vaccine supply, and to get it out the door as fast as possible. host: andrew dunn, the incoming president last night and what we are expected to hear in the coming days. guest: this was kind of part of his announcement of the $1.9 trillion proposal of relief and a lot of it focuses on the vaccine distribution effort. if you look at the mission to bring out mass vaccination sites and have a team of basically mobile units to reach rural areas to vaccinate people, it is a fundamentally different approach than we have seen with the trump administration where warp speed has focused on states, letting states drive and their language. we have seen this in other parts of the pandemic as far as ppe or setting up testing sites, that is up to the states. this response, we see some states doing quite well and others struggling based on the compensation -- competency and funding of your health officials. biden wants to have a coherent strategy across the u.s., and it will take significant moneys that will be inc

vaccine. and after today, over 90% of the residents at laguna honda will have received the first dose of the pfizer vaccine. that is great news. given the limited initial supply of covid-19 vaccine, the state has developed a phase approach for which group of people will get the vaccine and when. the first phase, the phase we are in now, defined by the state as phase 1a, prioritizes those workers in health care settings most likely to be exposed to the virus, and most needed to support our health care system. in san francisco, that is estimated to be over 80,000 health care workers, including nurses, doctors, technicians, environmental service workers, nutrition service workers, e.m.t.s, paramedics, and many, many others. the majority of these workers are being vaccinated by their employer, whether it be the health department, c.p. m. c., ucsf, kaiser, and so far. we are waiting for the state to finalize the next phase, which is proposed to include frontline essential workers, such as public sa

-19 vaccines as well.— vaccines as well.ite is there _ vaccines as well. and how much appetite is there amongst - vaccines as well. and how much l appetite is there amongst people vaccines as well. and how much - appetite is there amongst people to get the vaccine? what is that like and what if i going to be like in the coming years?— and what if i going to be like in the coming years? that is a very important _ the coming years? that is a very important question. _ the coming years? that is a very important question. we - the coming years? that is a very important question. we are - the coming years? that is a very important question. we are still| the coming years? that is a very l important question. we are still at the point where the supply is way below the demand and that as i become an issue. as the supply increases, we are going to want as many people to get the vaccine as possible. there has been some data that shows people are warming to the idea of the vaccine and as they see so many people getting get on tv or on

we envision a number of drive-thru mass vaccination clinics, where multiple people can be vaccinated at the same time, potentially in partnership with some of our university partners, and we we'll be able to do thousands of people within a day rather than just hundreds in a clinic. so we expect to do that in the week or two ahead. and we can confidently begin to make appointments for individuals over age 65. we have on our website the capacity to click on a link and be able to make an appointment for the vaccine, and for health care workers as well. so expect to see that, and lots of public information coming out about those clinics here, as well as in rural areas. i suspect that already many providers are beginning to offer vaccines because they have it in their freezers. and we will continue to roll that out very aggressively as we get the vaccine. there are two things i want to point out again. please be patient. we don't have as much vaccines as we have the need for vaccines, and we will have to make appointments so we can literally match the number of vaccine doses to the number

mit vaccines just yesterday 2 other very promising vaccines. announced that had a press release and i'm stepping down to advocacy reasons know about x. and and johnson and johnson and and yesterday also as as a nic i was approved by the european medicines agency that there are who are tools at hand down and they are much easier to use programatic lee are also scalable and and more convenient to use because they don't need to alter cold chain the quiet modes i think we need to move away from this focus on am i in a back seat and i really embrace that the normal banks in that are just now coming out in fact that now rapid succession also of other vaccines that are being discussed a debate or level to receive emergency use listing and i think that could be up to 7 new vaccines the next in the next 2 months so we need to we need to work on them as them julie looked to me like you wanted to jump in. no i just completely agree with what analisa saying that the focus only has been on the culture and requirements in the logistical lift required for the

vaccinated. i want that term to come. i feel with your leadership we are ready to do those people at the greatest risk and we look forward to working with you in the coming weeks to see them vaccinated. thank you. >> thank you so much. and what a beautiful story of your 98-year-old dad, world war ii hero still with us and i really admire your devotion to your mom and dad. it's something i appreciate. but everyone listen, that just doesn't expense. let's create the flexibility that is in the city, the freedom to vaccinate and give healthcare freedoms so some of 98 those that have the right to be vaccinated. we can do more than one thing at once. we can focus on vaccinating all the healthcare heroes that won the vaccine, all the folks in the nursing homes who want the vaccine expanding the categories reaching folks over 75, reaching educators, reaching police officers, reaching all of the folks that need to get the vaccine as quickly as possible. it is just common sense because we want to get the f

their vaccinations.hat's now no longer allowed. you do have to be a resident and 65 or older. there is some hope. the governor's gotten several hundred publix pharmacies enrolled and they are doing about 15,000 vaccinations a day. sanjay? >> yeah, randi, what about elsewhere in the country? i mean, we know it's before varying pretty wildly from state to state. i think kcnn's analysis shows some states have administered 40% of their doses, others as high as 80%. can you walk us through some of that? >> yeah, it is a mix of the good, bad and ugly. if you look at west virginia for example, that's a bright spot here in this vaccination process. they are second in the nation in terms of the numbers of the vaccines that they have administers per capita. they are just behind alaska. the governor there said they administered more than 100% of the vaccine supply they received. they've been able to squeeze out extra doses out of those viles. so they have administered about 106%, the governor said, about 9% of west

that is vaccines. as many of you know now, the federal government has been involved either in the development of or the facilitation of the testing of a number of vaccines that represent three separate platforms. shown on the slide is what we all know is the extraordinary efficacious and safe results of them a dharna and the pfizer biontech product with 94 to 95% efficacy and a good safety profile, both having received an eua. what we are looking at closely now is others that you see on the slide. astrazeneca, novavax which are in various states of trial. of particular importance which you will be hearing about are the results from j&j. the reason they are important, it relates to the things that dr. linsky said. it's a phase three trial. with a different platform, a human adenovirus vector. if you are looking at efficacy, not only in the united states, but also in south africa and brazil. we will get a good feel from those, i hope. we will let the data speak for itself. we will see the relative effica

and the vaccinations. i am pleased to announce the first progress in network today -- in that today. first, after review of the first vaccine supply, i can announce we will increase overall weekly vaccination distribution to states, tribes, and territories from 8.6 million doses to a minimum of 10 million doses. starting next week, 1.4 million doses per week. if i may note parenthetically, you all know vaccines are distributed to states based on population. so, the smaller the state, the less vaccine. the bigger the state, the more they get. the -- so this will allow millions more americans to get vaccinated sooner than anticipated. the second thing, we are increasingly transparency was states, cits, tribes, and local partners when it comes to the vaccine supply. this is something we have heard over and over again from both democrats and republicans, state and local leaders, that they need a plan. they need to know what they have to plan on, they need to know what the order will be. jeff had a meeting with

to take the vaccine.tant partners in this. we are starting the roll—out but there is much more to come. thank you all for your questions. that concludes today's coronavirus briefing. studio: the health secretary, announcing that 2.6 million vaccine doses have been given so far. they have been given to 2.3 million people. some people already getting their second dose of the vaccine. two fifths of those over 80 have had a first dose and the government is on track to vaccinate the top four priority groups by the middle of february. those priority groups, around 15 million people, account for 88% of covid deaths, and he explained that is why they have to be vaccinated as fast as possible, and he said more than 32,000 people are currently in hospital with covid—19. the average number of deaths with covid in the last week, 926 per day, said the health secretary. our health correspondent, nick triggle is here. talking about vaccinations so far, and every time i talk to you the number goes up, 2.6 million doses g

had called that when you were being vaccinated thus chains the protection that the vaccine office. well that's also the 1st bit of that after the 2nd question you asked which is well what happens if i've got coded right now and i go and get vaccinated now there are circumstances when we sometimes use vaccines to prevent people getting an infection because in the case of an infection with a very long incubation period sometimes the vaccine can give your immune system a head start and you never then develop the clinical syndrome that's not the case with this new coronavirus the vaccines don't confer protection soon enough to ward off infection so there will inevitably be people turning up for vaccination who have caught this thing and they could be incubating at that time this is not a worry it's not a concern and it won't do people any harm it might not actually help them to fight off the infection but it certainly won't do any harm there will also be people who have in the past had coronavirus and they're getting vaccinated again will that cause a problem again we don't think that'

to get your vaccine. that too will help us reopen a get back to normal faster. .. i last spoke with all of you in late spring about increasing our testing capacity throughout the state. i'm going to take a moment now, to discuss the state's vaccine distribution goals. our team is working around the clock to help registered providers. there are over 1218 of them. but as many shots in arms as possible each day. we have remained flexible so that we can adjust to whatever news we are from the federal government about either more or less supply. certainty in the number of doses and timing of doses is essential to efficiently administer vaccine appointments. there is currently not enough supply to allow every eligible michigander to obtain a vaccine appointment. we are as disappointed as you. our overall goal is to get at least 70% of michiganders ages 16 and older vaccinated as soon as possible, you have heard that. that means 5.6 million residents. in the best of circumstances, this will take considerable tim

the moderna vaccine as well as the pfizer vaccine. based on our most recent data, we saw that there was two .1 cases of anaphylaxis per million administered doses of moderna and six point two cases of anaphylaxis per million doses administered of pfizer. let me be clear, these are rare, treatable outcomes, and the covid vaccine is safe. it's also important to put this into context. the risk of getting sick with covid-19 is much higher than the risk of allergy or anaphylaxis from the vaccine. sadly, approximately 16,500 people for every one million who are diagnosed with covid, will die. while anaphylaxis can be scary, there are effective treatments and patients generally do quite well. it's also important to note the mild side effects. feverish or tired, and muscle aches. these are all normal, especially getting the second dose. it means that your immune system is revving up and the vaccine is working. cdc is actively monitoring for safety signals associated with these vaccines and we are committed to sharing those safety data with yo

know with the other vaccines they have told me the only vaccine i have taken and can is the flu vaccine. pneumonia and all the others i cannot take for sure. i don't know. it is kind of scary for people who have had transplant, you know? you have to take immunosuppressants and you have got to be careful. i have been lucky. just wear our mask and stay away from people. from we go to mary calling new port richey, florida. she says she will take it. good morning. caller: good morning. i will take it but the county says you sign into the computer. when you call in they do not have the information. i'm on a waiting list for my doctor's office and cvs does not know when, they're giving in the parking lots. you have to go on the computer and they do not have a computer available. i will get it. i have four children in the nursing field. host: let's go to linda calling from trenton, michigan and she will get it as well. good morning. linda, are you there? i seem to have lost linda. we go to kenneth calling from buffalo, new york. good morning. caller: good morning. i am 88 years old. i intend t

, you can approve astrazeneca and johnson & johnson vaccine which is a single dose vaccine, it's a lot easier and other drug companies that are working on vaccines, we hope, pray and expect the supply from the federal government will be increasing, we needed to increase, then you gon to the distribution side, on distribution, the federal government is in charge of some of the distribution in the state and in the state is in charged, distribution as we discussed yesterday think in three tranches, nursing home, hospital and what we call special efforts. the nursing home program is run by the federal government and it is a federal, national federal program and they said will do the nursing homes and contract nationally withti pharmaceutical chains to do the nursing homes. that has not moved as quickly as we would like to see it move, the state will step in and expedite that program, we would like to see all nursing home residents vaccinated first shots within two weeks, they're doing the staff along with the residents, that would be a big deal if we can get the nursing home residents vacc

the vaccine uses mrna technology, which is a breakthrough technology for vaccinations. inow, can you explain to laymen's terms exactly what is going on inside of a person's body when they receive a dose of pfizer's shot? >> when they receive a dose of izer's shot, they are geing a very large number of sma lipid nanoparticles. so, this is very small pieces of lipid. and inside each one of these particles, there is a code that it is an rna code. i remind you that rna code -- messenger rna -- is the way that the ces are replicating information about dna. so, to make a long story short, this messenger rna, it is a code that will tell our cells to produce proteins that they are similar like the proteins that the vaccine has. and that will create an immune respse from our body as this is happening.te >> the mrnnology is a breakthrough technology for vaccines. what does it mean for the future of vaccines? >> i think, great ne. i think that mrna technology is here to stay. i believe that in the future, this technology will be used toy produce ore vaccines against viruses, but also ie beli wi

vaccine i_ astrazeneca vaccine and the moderna vaccine._ vaccine. the vaccine effectiveness after the — vaccine. the vaccine effectiveness after the first dose has been reported by the manufacturers and others _ reported by the manufacturers and others as— reported by the manufacturers and others as being, which counts after day one. _ others as being, which counts after day one, the first dose to the second — day one, the first dose to the second dose, which is around 21 days _ second dose, which is around 21 days we — second dose, which is around 21 days. we know that vaccines do not work _ days. we know that vaccines do not work immediately. if i receive a vaccine — work immediately. if i receive a vaccine today i am not protected tomorrow — vaccine today i am not protected tomorrow. it takes about two weeks for the _ tomorrow. it takes about two weeks for the immune response to be generated before i can become protected. public health england have therefore taken the data from the vaccine — have therefore taken the data from the vaccin

be out of this pandemic because i mean it's not just the vaccine is the vaccination that helps so more people will take it the higher the herd immunity chances are but also to really get into trust and i think once the trials for the sport need to be announced as i think i would start and become observers become publicly available i is is going to gain or what it has lost but all in all i would say this is reaching all those benchmarks that are required for a quality vaccine one of the main focuses right now is that new strain that was 1st found in the u.k. we had the u.k. going into a 3rd lockdown at this point our moscow medics right to say that sputnik the shields from that new variant. well look let me clarify this one that all the cool vaccine or the ones that are closer to approved for example astronomical. spoken at least i know back they have stored a construct in the vaccine at the same toiling at that point there was a single kind of and good in that single kind of virus that was available so this means that if one of axion were horrific the rest of the vaccine want to work a

can get vaccinated. hopefully, we will have by contractual arrangement the hundreds of millions of doses that will be necessary to vaccinate, which as i have been saying, we want to aim at 75%-85 percent of people in the country vaccinated. again, challenging times as we speak, but encouraging times because vaccines are starting to be rolled out. steve: how would you fix this so that when america and the world is hit by the next pandemic, we are better prepared, not just in science, but doing the things we need to do? dr. fauci a: -- dr. fauci: well, there are certain things we want to continue to do and certain things we want to improve, steve. the shining light of all this was the fruits of the science, the fact that given the brand-new platform technology for a vaccines, the ability to utilize infrastructure of clinical trial networks that were set up decades ago for hiv , you might recall we put so much investment years ago into the fundamental, basic science that made vaccines successful. so in the

up the vaccine.ative that has been developing over the last few days, about two issues to do with the vaccination programme. the 12 week wait that has been introduced, but also the changing guidance about what a last resort mix and match of different types of vaccines would be. so, really, we wanted to get clarity on those key issues, to make sure that this programme was as transparent as possible, so people will continue to have public confidence in it. but it does make sense, doesn't it, to give people firstjabs and then delay the second jabs, if by doing that you can vaccinate more people, more quickly? the deputy chief medical officer, jonathan van—tam, he has an analogy where he says if you've got two elderly grandparents, there are two vaccines available, it's better to give both 89% protection than to give one 95% protection, with two quick doses, and the other no protection at all. that makes logical sense, doesn't it? yes, it does, but i also think that you have to understand that people nee

hold in india and vaccine an indigenous vaccine developed by part of biotech. but as the country takes a crucial step towards battling the pandemic many concerns loom large there are questions being raised on call vaccine getting approval from india to targeting without its efficacy data in place as its 50 trials are still underway some experts say that this is a break from established protocol and could lead to at best just among people who however there's no clear consensus on this issue in the medical community doctor that in there it's john a leading that's knowledge it says the approval to call vaccine has been given to lying on the date of immunogenicity and safety he says such image and see government approvals are not uncommon in unusual circumstances. masses and masses have. to accept. to come in the transporter community should there. and communication. using 2 people even though there are actual voices regarding the image and see approval many working in the health care sector are confident that vaccination is the right step to take we are in that ti

gets vaccinated? i want dr. katz to talk about having.rience he's if anyone's working in a hospital they're helping us. if anyone is working in a they're supporting our health care heroes. if anyone is working in a ospital, they are putting themselves into some kind of proximity to folks who have the coronavirus. again, i want dr. katz to have the right to vaccinate into over 75 who comes one of his hospitals or clinics for any reason at all. don't care if they stub their toe. i want them to have the right to ave a vaccine if they're over 75. dr. katz. dr. katz: thank you so much for about hospital and health care employees. great.s me feel so starting yesterday, i can now vaccinate everyone in the mayor l, as the explained. and we'll continue to walk through the hospital to make knows that erybody vaccinations are available. they are right at the site so eople don't have to go anywhere. although they also have the choi hoice, if they wish to get vaccinated at a site that may be closer to their home,

even as people get vaccinated. that means helping working people get, who get covid and who need to take time off from work to isolate. in the absence of real programming from the federal government, the city has been at the forefront of providing financial relief through the right to recover program. so far, 4.5 million for the program. many from our latino community, which we all know has been disproportionately impacted by covid. today, another $6 million going forward, total support to $10.5 million. we are doing this by tapping into unused funds paid into our healthcare security ordinance funds, which is usually used to provide health insurance for workers. early in this pandemic we used the funds in the healthcare security ordinance to provide $500 checks of need relief to people who qualify like restaurant workers and bar workers. now providing direct financial assistance for those who test positive during the pandemic. fulfilling the ideas of the healthcare security ordinance and thank our labor partners an

a vaccination centre without any vaccine.on the eu to place its orders, a decision which may have come at a cost. translation: we really feel it here. people keep asking us why we haven't been vaccinated yet. at the end of the day, these are political decisions which i have to accept, but i am looking forward to the time when we have enough vaccine and can get on with it. no tourists now for city guide teresia. immunity would bring life back to marburg's streets, restart the german economy. butjust 2% of the population have had their first dose of the vaccine so far. even so, she tells us, it was right for the eu to order vaccine together. if everyone in germany gets vaccinated but not people in the countries around it, then the plague comes back over the border. if we do it, we should do it together, even if we have to wait. months of restrictions here appear to be paying off. germany's infection rates are now falling, but there's real concern about the impact of new variants, like those discovered in britain or south africa

vaccination sites. that is what we are about to harness the full resources of the federal government established thousands of community vaccination centers. on my first day in office, i will instruct the federal emergency management agency, fema, to begin setting up the first of these centers. by the end of our first month in office, we will have 100 federally supported centers across the nation that will ultimately vaccinate millions of people. think of the places that are convenient and accessible, school gymnasiums, sports stadiums, community centers. we have already had productive conversations with bipartisan groups of county officials, mayors, governors, tribal leaders, leaders in the private sector, who shared their ideas with us about this. and as we build, we are going to mixer it is done equitably we are going to make sure there are vaccination centers in communities hit hardest by the pandemic, in black and latino and rural communities as well. within the first month of our administration, we

the numbers that i gave you alst with regard to the vaccine that is remaining that those vaccines have been scheduled for second doses or appointments that have been made for first doses for most part. and with the d.p.h. supply, even with the 10,000, our total that we'll get this week, we will be scheduled to basically to exhaust our vaccine supply by as early as wednesday or thursday. we need more vaccine right now so that we can get those shots into arms. >> thank you, dr. colfax. the next set of questions come from alex fererria, san francisco business times. in what ways will the restrictions in place in san francisco be on thursday differ from what the state is allowing in the purple tier counties? or, is the county reopening to the full extent of the purple tier? >> so just to be clear right nod that the counties are coming out as the shelter-in-place order, we will be told what tier we're in tomorrow. we'll look at that very carefully. and with regard to the orders, those will be -- be released accordingly. and that those will be released on thursday at this time. >> thank you,

an vaccine.ow that would be used in practice is uncertain. there are a lot of people who would say, i am not interested vaccine, i would like to get one of the ones that is 95%. -- toould try -- i think seek after the more effective vaccine. so, i hope the new ones coming levels effectiveness that are comparable to both pfizer and moderna. ,ost: here is one headline death of florida doctor after receiving vaccine under investigation. have you been studying that case? guest: it is under investigation. these events are going to occur. we are giving the vaccine to , many who are older, many who are residents of nursing homes. they already have underlying illnesses of a greater variety. we can't anticipate that if we give the vaccine on monday, some people will have an adverse medical event that occurs on wednesday. so then the question will be, are those two coincidental? precipitate,accine or cause that second event? we are going to have to try to tease that apart. there is a surveillance system th

vaccine. they distribute it in three main ways. one, they allocate to the states. second, they enter into partnerships with certain pharmacies such as walgreens and cvs. thirdly they directly allocate to the va. the san francisco va gets them directly from the federal government. once it goes to the states. they allocate to the multi county entities. those are many the keysser, dignity hospitals. these systems span multiple counties. they are called multi-county programs. then the state also distributed to lomhealth departments. such as san francisco department of public health. we get an allocation and distribute to the health network, sf general hospital and other healthcare facilities not part of the multi county entity program. one medical, chinese hospital, northeast medical services. those are the ones that don't span multiple counties. some do but they are not officially part of the multi county entity program. that i hope gives you a little sense of just how the vaccine ends up in san

because we never got 80 5000 --es of vaccine here, right 85,000 doses of vaccine here, right?would be great. >> a couple quick follow-ups. there is a report of the d.c. council, saying that there was concern a successful insurrection would seize control from the district. how big concern was that? how do you classify what the district knew? i think you are referring to a memo i have not seen that our attorney general generals into councilmembers that talked about presidential power in the district. people who do not know thethe district is set up, president of the united states commandeeremergency policeropolitan department. we experienced this threat from the president in january -- in june, sorry. dealing withys this -- what does that say? does that speak to the level of concern -- of preparation or concern. i have seen a lot of demonstrations. i have seen several inaugurations. one that had a million people or more for president obama and even the last one, we had a andion women come here people coming to demonstrate peacefully are very different than the people we saw stor

vaccination. and use the community to identify and walgreens, c.v.s., and other areas that can participate in doing these vaccinations. and to work with the community hub as a way to communicate and get to these places to move to mass vaccination. and work with specialty pharmacies that have a history of working with the immigrant and undocumented populations. the duty is not just on the department of public health but the covid command center and also on the responsibility of our private sector hospitals as well. ucsf has taken a proactive role and i want to commend them for working with the latino task force and others in the community to be part of the testing process and to learn how to better respond to this. we need more private employers and i am glad they are here today to be part of this process about how we're going to move toward ensuring that the most impacted areas of san francisco are part of the response and are part of the vaccination process. and my district is in many ways a medi

and china bs vaccine has been cleared in six countries. -- and china's vaccine has been cleared in sixes. it's mainly wealthier nations that are getting these vaccines and that concerns the world health organization. thwho has called on countries to think about the less religious. >> they are at the end of the queue right now. the people at the top of the queue are fighting about where they are in the queue, they are fighting over this. we need to step back and reflect on our colleagues and where they stand today and what we are going to do about that. anchor: let's talk to ellen marriott, an advisor. it would be good if there was uality in vaccine rollout, but if anything, the row between the eu and these major vaccine producers show there is not much equality right now, is there? >> know, and they are at the heart -- no, and at the heart of the challenges facing the eu is a vaccine scarcity problem. we know that is multiplied many times over if you look at the access of these vaccines across the globe. our research, as the people's vaccine alliance shows nine in 10 people in the poor